1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.
Cell 1993;75:843-54.
2. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet 2010;11:597-610.
3. Bartel DP. MicroRNAs: target recognition and regulatory functions.
Cell 2009;136:215-33.
4. Ye J, Xu M, Tian X, et al. Research advances in the detection of miRNA.
J Pharm Anal 2019;9:217-26.
6. Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans.
Nature 2000;403:901-6.
7. Pasquinelli A. The primary target of let-7 MicroRNA.
FASEB J 2016;30(S1):507.
8. Rassi DM, De Paiva CS, Dias LC, et al. Review: microRNAs in ocular surface and dry eye diseases.
Ocul Surf 2017;15:660-9.
9. O’Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation.
Front Endocrinol (Lausanne) 2018;9:402.
10. Ha M, Kim VN. Regulation of microRNA biogenesis.
Nat Rev Mol Cell Biol 2014;15:509-24.
11. Achkar NP, Cambiagno DA, Manavella PA. miRNA biogenesis: a dynamic pathway.
Trends Plant Sci 2016;21:1034-44.
12. Kawahara Y. Human diseases caused by germline and somatic abnormalities in microRNA and microRNA-related genes.
Congenit Anom (Kyoto) 2014;54:12-21.
13. Qiu X, Zhang H, Yu H, et al. Duplex-specific nuclease-mediated bioanalysis.
Trends Biotechnol 2015;33:180-8.
14. Lao TD, Le TA. MicroRNAs: biogenesis, functions and potential biomarkers for early screening, prognosis and therapeutic molecular monitoring of nasopharyngeal carcinoma.
Processes 2020;8:966.
17. Nik Mohamed Kamal NN, Awang RA, Mohamad S, Shahidan WN. Plasma- and saliva exosome profile reveals a distinct microRNA signature in chronic periodontitis.
Front Physiol 2020;11:587381.
18. Macfarlane LA, Murphy PR. MicroRNA: biogenesis, function and role in cancer.
Curr Genomics 2010;11:537-61.
19. Karali M, Peluso I, Marigo V, Banfi S. Identification and characterization of microRNAs expressed in the mouse eye.
Invest Ophthalmol Vis Sci 2007;48:509-15.
20. Wienholds E, Koudijs MJ, van Eeden FJ, et al. The microRNA-producing enzyme Dicer1 is essential for zebrafish development.
Nat Genet 2003;35:217-8.
21. Bernstein E, Kim SY, Carmell MA, et al. Dicer is essential for mouse development.
Nat Genet 2003;35:215-7.
22. Wienholds E, Kloosterman WP, Miska E, et al. MicroRNA expression in zebrafish embryonic development.
Science 2005;309:310-1.
23. Shalom-Feuerstein R, Serror L, De La Forest Divonne S, et al. Pluripotent stem cell model reveals essential roles for miR-450b5pand miR-184 in embryonic corneal lineage specification.
Stem Cells 2012;30:898-909.
24. Lee ST, Chu K, Im WS, et al. Altered microRNA regulation in Huntington’s disease models.
Exp Neurol 2011;227:172-9.
26. Xu S. microRNA expression in the eyes and their significance in relation to functions.
Prog Retin Eye Res 2009;28:87-116.
27. Yanoff M, Sassani JW. Ocular pathology. 7th ed. Philadelphia: Saunders; 2014.
28. Sun W, Sheng Y, Chen J, et al. Down-regulation of miR-146a expression induces allergic conjunctivitis in mice by increasing TSLP level.
Med Sci Monit 2015;21:2000-7.
29. Yang Y, Yin X, Yi J, Peng X. MiR-146a overexpression effectively improves experimental allergic conjunctivitis through regulating CD4+CD25-T cells.
Biomed Pharmacother 2017;94:937-43.
30. Guo C, Liu J, Hao P, et al. The potential inhibitory effects of miR-19b on ocular inflammation are mediated upstream of the JAK/STAT pathway in a murine model of allergic conjunctivitis.
Invest Ophthalmol Vis Sci 2020;61:8.
31. Bai M, Li Y, Li Y, Hu Z. Influence of miR155 on allergic conjunctivitis in mice via regulation of NF-κB signal pathway. Trop J Pharm Res 2019;18:1603-8.
32. Cai J, Liu X, Cheng J, et al. MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2.
Graefes Arch Clin Exp Ophthalmol 2012;250:523-31.
33. Hother C, Rasmussen PK, Joshi T, et al. MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.
Invest Ophthalmol Vis Sci 2013;54:5169-75.
34. Larsen AC, Mikkelsen LH, Borup R, et al. MicroRNA expression profile in conjunctival melanoma.
Invest Ophthalmol Vis Sci 2016;57:4205-12.
35. Mikkelsen LH, Andersen MK, Andreasen S, et al. Global microRNA profiling of metastatic conjunctival melanoma.
Melanoma Res 2019;29:465-73.
36. Ranjbarnejad F, Nadri S, Biglari A, et al. Effect of let-7a overexpression on the differentiation of conjunctiva mesenchymal stem cells into photoreceptor-like cells.
Iran J Basic Med Sci 2019;22:878-83.
37. Rajic J, Dinic S, Uskokovic A, et al. DNA methylation of miR-200 clusters promotes epithelial to mesenchymal transition in human conjunctival epithelial cells.
Exp Eye Res 2020;197:108047.
38. Chien KH, Chen SJ, Liu JH, et al. Correlation of microRNA-145 levels and clinical severity of pterygia.
Ocul Surf 2013;11:133-8.
39. Engelsvold DH, Utheim TP, Olstad OK, et al. miRNA and mRNA expression profiling identifies members of the miR-200 family as potential regulators of epithelial-mesenchymal transition in pterygium.
Exp Eye Res 2013;115:189-98.
40. Wu CW, Peng ML, Yeh KT, et al. Inactivation of p53 in pterygium influence miR-200a expression resulting in ZEB1/ZEB2 up-regulation and EMT processing.
Exp Eye Res 2016;146:206-11.
41. Wu CW, Cheng YW, Hsu NY, et al. MiRNA-221 negatively regulated downstream p27Kip1 gene expression involvement in pterygium pathogenesis.
Mol Vis 2014;20:1048-56.
42. Lan W, Chen S, Tong L. MicroRNA-215 regulates fibroblast function: insights from a human fibrotic disease.
Cell Cycle 2015;14:1973-84.
43. Han S, Chen Y, Gao Y, et al. MicroRNA-218-5p inhibit the migration and proliferation of pterygium epithelial cells by targeting EGFR via PI3K/Akt/mTOR signaling pathway.
Exp Eye Res 2019;178:37-45.
44. Cui YH, Li HY, Gao ZX, et al. Regulation of apoptosis by miR-122 in pterygium via targeting Bcl-w.
Invest Ophthalmol Vis Sci 2016;57:3723-30.
45. Li X, Dai Y, Xu J. MiR-21 promotes pterygium cell proliferation through the PTEN/AKT pathway.
Mol Vis 2018;24:485-94.
46. Teng Y, Yam GH, Li N, et al. MicroRNA regulation of MDM2-p53 loop in pterygium.
Exp Eye Res 2018;169:149-56.
47. Zhong X, Tang J, Li H, et al. MiR-3175 promotes epithelial-mesenchymal transition by targeting Smad7 in human conjunctiva and pterygium.
FEBS Lett 2020;594:1207-17.
48. Icme G, Yilmaz A, Dinc E, et al. Assessment of miR-182, miR-183, miR-184, and miR-221 expressions in primary pterygium and comparison with the normal conjunctiva.
Eye Contact Lens 2019;45:208-11.
49. Hwang YH, Jung SA, Lyu J, et al. Transforming growth factor-β1-induced human subconjunctival fibrosis is mediated by microRNA 143/145 expression.
Invest Ophthalmol Vis Sci 2019;60:2064-71.
51. Derrick T, Roberts Ch, Rajasekhar M, et al. Conjunctival MicroRNA expression in inflammatory trachomatous scarring.
PLoS Negl Trop Dis 2013;7:e2117.
52. Derrick T, Last AR, Burr SE, et al. Inverse relationship between microRNA-155 and −184 expression with increasing conjunctival inflammation during ocular Chlamydia trachomatis infection.
BMC Infect Dis 2016;16:60.
53. Derrick T, Ramadhani AM, Mtengai K, et al. miRNAs that associate with conjunctival inflammation and ocular Chlamydia trachomatis infection do not predict progressive disease.
Pathog Dis 2017;75:ftx016.
54. Latta L, Ludwig N, Krammes L, et al. Abnormal neovascular and proliferative conjunctival phenotype in limbal stem cell deficiency is associated with altered microRNA and gene expression modulated by PAX6 mutational status in congenital aniridia.
Ocul Surf 2021;19:115-27.
55. La Rosa M, Lionetti E, Reibaldi M, et al. Allergic conjunctivitis: a comprehensive review of the literature.
Ital J Pediatr 2013;39:18.
57. Negrini M, Nicoloso MS, Calin GA. MicroRNAs and cancer: new paradigms in molecular oncology.
Curr Opin Cell Biol 2009;21:470-9.
58. Lawrie CH, Soneji S, Marafioti T, et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma.
Int J Cancer 2007;121:1156-61.
59. Eis PS, Tam W, Sun L, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas.
Proc Natl Acad Sci U S A 2005;102:3627-32.
61. Dalvin LA, Salomao DR, Patel SV. Population-based incidence of conjunctival tumours in Olmsted County, Minnesota.
Br J Ophthalmol 2018;102:1728-34.
62. Wong JR, Nanji AA, Galor A, Karp CL. Management of conjunctival malignant melanoma: a review and update.
Expert Rev Ophthalmol 2014;9:185-204.
63. Mikkelsen LH, Larsen AC, von Buchwald C, et al. Mucosal malignant melanoma: a clinical, oncological, pathological and genetic survey.
APMIS 2016;124:475-86.
64. Larsen AC, Dahl C, Dahmcke CM, et al. BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions.
Acta Ophthalmol 2016;94:463-70.
65. Xiao C, Calado DP, Galler G, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb.
Cell 2007;131:146-59.
66. Kim YJ, Bae SW, Yu SS, et al. miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue.
J Bone Miner Res 2009;24:816-25.
67. La Torre A, Georgi S, Reh TA. Conserved microRNA pathway regulates developmental timing of retinal neurogenesis.
Proc Natl Acad Sci U S A 2013;110:E2362-70.
68. Chui J, Di Girolamo N, Wakefield D, Coroneo MT. The pathogenesis of pterygium: current concepts and their therapeutic implications.
Ocul Surf 2008;6:24-43.
69. Ando R, Kase S, Ohashi T, et al. Tissue factor expression in human pterygium.
Mol Vis 2011;17:63-9.
70. Kato N, Shimmura S, Kawakita T, et al. Beta-catenin activation and epithelial-mesenchymal transition in the pathogenesis of pterygium.
Invest Ophthalmol Vis Sci 2007;48:1511-7.
71. Sotozono C, Ueta M, Nakatani E, et al. Predictive factors associated with acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Am J Ophthalmol 2015;160:228-37.
72. Ueta M, Nishigaki H, Sotozono C, Kinoshita S. Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage.
BMJ Open Ophthalmol 2017;1:e000073..
73. Sato S, Ichihara A, Jinnin M, et al. Serum miR-124 up-regulation as a disease marker of toxic epidermal necrolysis.
Eur J Dermatol 2015;25:457-62.
74. Ichihara A, Wang Z, Jinnin M, et al. Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions.
J Allergy Clin Immunol 2014;133:1065-74.
75. Zhang C, Zhu Z, Gao J, et al. Plasma exosomal miR-375-3p regulates mitochondria-dependent keratinocyte apoptosis by targeting XIAP in severe drug-induced skin reactions.
Sci Transl Med 2020;12:eaaw6142.
76. Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness.
Br J Ophthalmol 2009;93:563-8.
78. Zhu Y, Jiang Q, Lou X, et al. MicroRNAs up-regulated by CagA of Helicobacter pylori induce intestinal metaplasia of gastric epithelial cells.
PLoS One 2012;7:e35147.